Compare $ORGS vs $REVB | Chartloom

Compare

$ORGS vs $REVB

Orgenesis Inc · Revelation Biosciences Inc

ORGS

Orgenesis Inc

REVB

Revelation Biosciences Inc

Compare $ORGS vs $REVB

Comparing Orgenesis Inc and Revelation Biosciences Inc

ORGSOrgenesis Inc

REVBRevelation Biosciences Inc

ORGSOrgenesis Inc

Market cap

$3M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-92.8%

YTD performance

133.3%

52W performance

-56.3%

FCF yield

-505.5%

REVBRevelation Biosciences Inc

Market cap

$3M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-76.6%

52W performance

-87.1%

FCF yield

-317.7%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ORGS

REVB

Detailed metrics comparison

ORGS

Orgenesis Inc

REVB

Revelation Biosciences Inc

Market Cap

ORGS$3M

REVB$3M

Enterprise Value

ORGS$20M

REVB$-9M

Price

ORGS$0.35

REVB$0.76

P/E Ratio

ORGSN/A

REVBN/A

P/S Ratio

ORGS3.31x

REVB0.00x

EV/Sales

ORGS19.39x

REVB0.00x

EV/EBITDA

ORGS0.00x

REVB0.00x

P/B Ratio

ORGS0.28x

REVB0.30x

P/FCF Ratio

ORGSN/A

REVBN/A

EV/FCF

ORGS-1.16x

REVB0.90x

PEG Ratio

ORGSN/A

REVBN/A

Forward P/E (NTM)

ORGSN/A

REVBN/A

Forward P/S (NTM)

ORGSN/A

REVBN/A

Revenue (TTM)

ORGS$1M

REVB$0

Revenue Growth (YoY)

ORGS-92.8%

REVBN/A

Forward Rev Growth

ORGS0.0%

REVB115.3%

Gross Margin (TTM)

ORGS-86.3%

REVB0.0%

Operating Margin (TTM)

ORGS0.0%

REVB0.0%

EBITDA Margin (TTM)

ORGS-1868.2%

REVB0.0%

Net Margin (TTM)

ORGS-4653.6%

REVB0.0%

FCF Margin (TTM)

ORGS-1675.3%

REVBN/A

Net Income (TTM)

ORGS$-48M

REVB$-19M

FCF (TTM)

ORGS$-17M

REVB$-9M

EPS (TTM)

ORGS-$9.58

REVB-$5.01

ROE (TTM)

ORGS-10936.0%

REVB-10020.0%

ROA (TTM)

ORGS-20820.0%

REVB-8273.0%

ROIC (TTM)

ORGS-5864.0%

REVB-10020.0%

Cash

ORGS$78K

REVB$11M

Debt

ORGS$17M

REVB$0

Net Cash/Debt

ORGS$-17M

REVB$11M

Current Ratio (TTM)

ORGS0.03x

REVB6.21x

Quick Ratio (TTM)

ORGS0.03x

REVB6.11x

Debt/Equity (TTM)

ORGS1.73x

REVB0.00x

Debt/Assets (TTM)

ORGS0.0%

REVB0.0%

Interest Coverage (TTM)

ORGSN/A

REVBN/A

Net Debt/EBITDA (TTM)

ORGS0.00x

REVB0.00x

Beta

ORGS3.73

REVB-0.14

52W Performance

ORGS-56.3%

REVB-87.1%

YTD Performance

ORGS133.3%

REVB-76.6%

% from 52W High

ORGS-65.0%

REVB-87.8%

% from 52W Low

ORGS34900.0%

REVB1.3%

Asset Turnover (TTM)

ORGS0.04x

REVB0.00x

FCF Yield (TTM)

ORGS-505.5%

REVB-317.7%

Earnings Yield (TTM)

ORGS-1404.2%

REVB-646.3%

Dividend Yield (TTM)

ORGSN/A

REVBN/A

Rule of 40

ORGS-1,768.0

REVB0.0

EV/GP/RG

ORGSN/A

REVBN/A

Ticker research

View ORGS research View REVB research

Metric	ORGS Orgenesis Inc	REVB Revelation Biosciences Inc
Market & Valuation
Market Cap	$3M	$3M
Enterprise Value	$20M	$-9M
Price	$0.35	$0.76
P/E Ratio	N/A	N/A
P/S Ratio	3.31x	0.00x
EV/Sales	19.39x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.28x	0.30x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.16x	0.90x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$1M	$0
Revenue Growth (YoY)	-92.8%	N/A
Forward Rev Growth	0.0%	115.3%
Profitability
Gross Margin (TTM)	-86.3%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-1868.2%	0.0%
Net Margin (TTM)	-4653.6%	0.0%
FCF Margin (TTM)	-1675.3%	N/A
Net Income (TTM)	$-48M	$-19M
FCF (TTM)	$-17M	$-9M
EPS (TTM)	-$9.58	-$5.01
ROE (TTM)	-10936.0%	-10020.0%
ROA (TTM)	-20820.0%	-8273.0%
ROIC (TTM)	-5864.0%	-10020.0%
Financial Health
Cash	$78K	$11M
Debt	$17M	$0
Net Cash/Debt	$-17M	$11M
Current Ratio (TTM)	0.03x	6.21x
Quick Ratio (TTM)	0.03x	6.11x
Debt/Equity (TTM)	1.73x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	3.73	-0.14
52W Performance	-56.3%	-87.1%
YTD Performance	133.3%	-76.6%
% from 52W High	-65.0%	-87.8%
% from 52W Low	34900.0%	1.3%
Efficiency & Yields
Asset Turnover (TTM)	0.04x	0.00x
FCF Yield (TTM)	-505.5%	-317.7%
Earnings Yield (TTM)	-1404.2%	-646.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-1,768.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ORGS research	View REVB research

Valuation

P/S Ratio

REVB

0.00x

ORGS

3.31x

EV/FCF

ORGS

-1.16x

REVB

0.90x

Growth & revenue

Revenue Growth TTM

ORGS

-92.8%

Forward Revenue Growth

REVB

115.3%

ORGS

0.0%

Profitability & performance

Gross Margin

REVB

0.0%

ORGS

-86.3%

ROE

REVB

-10020.0%

ORGS

-10936.0%

FCF Yield %

REVB

-317.7%

ORGS

-505.5%

52-Week Performance

ORGS

-56.3%

REVB

-87.1%

Detailed metrics comparison

ORGS

Orgenesis Inc

REVB

Revelation Biosciences Inc

Market Cap

ORGS$3M

REVB$3M

Enterprise Value

ORGS$20M

REVB$-9M

Price

ORGS$0.35

REVB$0.76

P/E Ratio

ORGSN/A

REVBN/A

P/S Ratio

ORGS3.31x

REVB0.00x

EV/Sales

ORGS19.39x

REVB0.00x

EV/EBITDA

ORGS0.00x

REVB0.00x

P/B Ratio

ORGS0.28x

REVB0.30x

P/FCF Ratio

ORGSN/A

REVBN/A

EV/FCF

ORGS-1.16x

REVB0.90x

PEG Ratio

ORGSN/A

REVBN/A

Forward P/E (NTM)

ORGSN/A

REVBN/A

Forward P/S (NTM)

ORGSN/A

REVBN/A

Revenue (TTM)

ORGS$1M

REVB$0

Revenue Growth (YoY)

ORGS-92.8%

REVBN/A

Forward Rev Growth

ORGS0.0%

REVB115.3%

Gross Margin (TTM)

ORGS-86.3%

REVB0.0%

Operating Margin (TTM)

ORGS0.0%

REVB0.0%

EBITDA Margin (TTM)

ORGS-1868.2%

REVB0.0%

Net Margin (TTM)

ORGS-4653.6%

REVB0.0%

FCF Margin (TTM)

ORGS-1675.3%

REVBN/A

Net Income (TTM)

ORGS$-48M

REVB$-19M

FCF (TTM)

ORGS$-17M

REVB$-9M

EPS (TTM)

ORGS-$9.58

REVB-$5.01

ROE (TTM)

ORGS-10936.0%

REVB-10020.0%

ROA (TTM)

ORGS-20820.0%

REVB-8273.0%

ROIC (TTM)

ORGS-5864.0%

REVB-10020.0%

Cash

ORGS$78K

REVB$11M

Debt

ORGS$17M

REVB$0

Net Cash/Debt

ORGS$-17M

REVB$11M

Current Ratio (TTM)

ORGS0.03x

REVB6.21x

Quick Ratio (TTM)

ORGS0.03x

REVB6.11x

Debt/Equity (TTM)

ORGS1.73x

REVB0.00x

Debt/Assets (TTM)

ORGS0.0%

REVB0.0%

Interest Coverage (TTM)

ORGSN/A

REVBN/A

Net Debt/EBITDA (TTM)

ORGS0.00x

REVB0.00x

Beta

ORGS3.73

REVB-0.14

52W Performance

ORGS-56.3%

REVB-87.1%

YTD Performance

ORGS133.3%

REVB-76.6%

% from 52W High

ORGS-65.0%

REVB-87.8%

% from 52W Low

ORGS34900.0%

REVB1.3%

Asset Turnover (TTM)

ORGS0.04x

REVB0.00x

FCF Yield (TTM)

ORGS-505.5%

REVB-317.7%

Earnings Yield (TTM)

ORGS-1404.2%

REVB-646.3%

Dividend Yield (TTM)

ORGSN/A

REVBN/A

Rule of 40

ORGS-1,768.0

REVB0.0

EV/GP/RG

ORGSN/A

REVBN/A

Ticker research

View ORGS research View REVB research

Metric	ORGS Orgenesis Inc	REVB Revelation Biosciences Inc
Market & Valuation
Market Cap	$3M	$3M
Enterprise Value	$20M	$-9M
Price	$0.35	$0.76
P/E Ratio	N/A	N/A
P/S Ratio	3.31x	0.00x
EV/Sales	19.39x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.28x	0.30x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.16x	0.90x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$1M	$0
Revenue Growth (YoY)	-92.8%	N/A
Forward Rev Growth	0.0%	115.3%
Profitability
Gross Margin (TTM)	-86.3%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-1868.2%	0.0%
Net Margin (TTM)	-4653.6%	0.0%
FCF Margin (TTM)	-1675.3%	N/A
Net Income (TTM)	$-48M	$-19M
FCF (TTM)	$-17M	$-9M
EPS (TTM)	-$9.58	-$5.01
ROE (TTM)	-10936.0%	-10020.0%
ROA (TTM)	-20820.0%	-8273.0%
ROIC (TTM)	-5864.0%	-10020.0%
Financial Health
Cash	$78K	$11M
Debt	$17M	$0
Net Cash/Debt	$-17M	$11M
Current Ratio (TTM)	0.03x	6.21x
Quick Ratio (TTM)	0.03x	6.11x
Debt/Equity (TTM)	1.73x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	3.73	-0.14
52W Performance	-56.3%	-87.1%
YTD Performance	133.3%	-76.6%
% from 52W High	-65.0%	-87.8%
% from 52W Low	34900.0%	1.3%
Efficiency & Yields
Asset Turnover (TTM)	0.04x	0.00x
FCF Yield (TTM)	-505.5%	-317.7%
Earnings Yield (TTM)	-1404.2%	-646.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-1,768.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ORGS research	View REVB research